ADAPFI

Entreprises (Petites et Moyennes Entreprises, Industrie)

www.adapfi.comvilleneuve tolosane, France
3 visites de profil

Détails

ADAPFI SAS is a French deep-tech SME based near Toulouse, developing adaptive and confidence-aware artificial intelligence for complex dynamic systems.

Its expertise includes adaptive modelling, state estimation, multimodal data fusion, longitudinal prediction, anomaly detection, uncertainty quantification and intelligent decision support. ADAPFI’s technologies are designed to remain reliable when data are noisy, incomplete, heterogeneous or affected by changing conditions.

In healthcare, ADAPFI develops solutions for predictive biomarkers, personalised medicine, Virtual Human Twins, treatment-response prediction and the monitoring of biotherapies. Its confidence-aware architecture can detect unreliable predictions and abstain or revert to predefined clinical strategies when the available evidence is insufficient.

ADAPFI is seeking cooperation with hospitals, clinical research centres, universities, biotechnology companies and health-data organisations possessing longitudinal cohorts, multimodal biomarkers, omics, imaging or treatment-response data. The objective is to jointly develop and validate trustworthy AI solutions for Horizon Europe Cluster 1 projects addressing chronic diseases, healthy ageing, personalised therapies and clinical decision support.

Réseaux sociaux

Domaines d'activité

Médecine de précision et personnalisée

1. HORIZON HLTH 2027 01 CARE 02 – Personalized approaches to reduce risks from adverse drug reactions2. HORIZON HLTH 2027 02 DISEASE 01 two stage – Innovative healthcare interventions for non communicable diseases

Technologies de santé numérique, intelligence artificielle et soins de santé axés sur les données

1. HORIZON HLTH 2027 03 TOOL 04 – Virtual Human Twins (VHTs) for integrated clinical decision support3. HORIZON HLTH 2027 03 TOOL 01 two stage – Predictive biomarkers using AI for chronic diseases

Technologies de bioproduction et de médecine régénérative

3. HORIZON HLTH 2027 02 IND 02 two stage – Portable and versatile point of care diagnostics4. HORIZON HLTH 2027 02 DISEASE 14 two stage – Clinical trials for innovative interventions in neurodegenerative diseases

Représentants

founder, CTO

ADAPFI

Marketplace (2)